Strides Pharma Science jumps after its arm, RDIF enter into partnership

22 Mar 2021 Evaluate

Strides Pharma Science is currently trading at Rs. 781.35, up by 13.20 points or 1.72% from its previous closing of Rs. 768.15 on the BSE.

The scrip opened at Rs. 765.00 and has touched a high and low of Rs. 793.00 and Rs. 765.00 respectively. So far 35572 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1000.00 on 08-Jan-2021 and a 52 week low of Rs. 271.00 on 20-Mar-2020.

Last one week high and low of the scrip stood at Rs. 849.00 and Rs. 742.30 respectively. The current market cap of the company is Rs. 7002.52 crore.

The promoters holding in the company stood at 29.69%, while Institutions and Non-Institutions held 41.81% and 28.50% respectively.

Strides Pharma Science’s biopharmaceutical division -- Stelis Biopharma and The Russian Direct Investment Fund (RDIF) have partnered to produce, and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 million people. The agreement between RDIF and Stelis Biopharma was reached under the aegis of Enso Healthcare LLP (part of Enso Group), RDIF's coordination partner for sourcing Sputnik V vaccines in India.

Sputnik V, the world’s first registered vaccine against the novel coronavirus infection, is now approved for use in over 50 countries. Sputnik V is a two-dose vaccine which uses two different human adenoviral vectors in the course of vaccination.The vaccine demonstrates a 91.6% efficacy rate as confirmed by a peerreviewed study published in the prestigious medical journal, The Lancet, which found the vaccine to offer consistent and strong protective effect across all participant age groups. The parties intend to commence supplies from the Q3 of 2021. Stelis will also continue to work with the RDIF to provide additional supply volumes beyond the initial agreement.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×